Skip to main content

Table 4 The presence of SARS-CoV2 specific antibodies, in those who were tested positive vs. negative for the SARS-CoV2 rapid antigen kits

From: Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection

 

Ab Positive

Ab Negative

Total

SD-Biosensor Ag Positive

60 (32.1%)

127

187

SD-Biosensor Ag Negative

432 (24.6%)

1319

1751

Abbott Ag Positive

10 (26.3%)

28

38

Abbott Ag Negative

109 (18.1%)

493

602

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us